Cargando…

Prognostic Significance of Cyclin E1 Expression in Patients With Chordoma: A Clinicopathological and Immunohistochemical Study

PURPOSE: Chordomas are rare, slow-growing sarcomas without any accepted prognostic biomarkers. Owing to their proximity to critical neurovascular structures, discovering predictive biomarkers in chordoma has been a significant research effort because it may potentially reduce risky therapies in pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Ran, Dean, Dylan C., Thanindratarn, Pichaya, Hornicek, Francis J., Guo, Wei, Duan, Zhenfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705258/ https://www.ncbi.nlm.nih.gov/pubmed/33282745 http://dx.doi.org/10.3389/fonc.2020.596330

Ejemplares similares

T‐LAK cell‐originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma
por: Thanindratarn, Pichaya, et al.
Publicado: (2020)

T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma
por: Thanindratarn, Pichaya, et al.
Publicado: (2021)

Advances in immune checkpoint inhibitors for bone sarcoma therapy
por: Thanindratarn, Pichaya, et al.
Publicado: (2019)

Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma
por: Ma, Hangzhan, et al.
Publicado: (2021)

Tissue Microarray Immunohistochemical Detection of Brachyury Is Not a Prognostic Indicator in Chordoma
por: Zhang, Linlin, et al.
Publicado: (2013)

Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067
por: Shen, Shen, et al.
Publicado: (2020)

SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma
por: Guo, Tao, et al.
Publicado: (2022)

Clinicopathological and Prognostic Characteristics in Dedifferentiated/Poorly Differentiated Chordomas: A Pooled Analysis of Individual Patient Data From 58 Studies and Comparison With Conventional Chordomas
por: Liu, Fu-Sheng, et al.
Publicado: (2021)

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma
por: Ma, Hangzhan, et al.
Publicado: (2018)

Expression and Clinical Significance of High‐Mobility Group AT‐hook 2 (HMGA2) in Osteosarcoma
por: Cui, Juncheng, et al.
Publicado: (2022)

Clinicopathological significance of p16, cyclin D1, Rb and MIB-1 levels in skull base chordoma and chondrosarcoma
por: Liu, Jun-qi, et al.
Publicado: (2015)

MicroRNA-155 expression is independently predictive of outcome in chordoma
por: Osaka, Eiji, et al.
Publicado: (2015)

Prognostic and Clinicopathological Significance of E-Cadherin in Pancreatic Cancer Patients: A Meta-Analysis
por: Wang, Pengbo, et al.
Publicado: (2021)

Recurrent Chromosomal Copy Number Alterations in Sporadic Chordomas
por: Le, Long Phi, et al.
Publicado: (2011)

The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer
por: Zhou, Yubing, et al.
Publicado: (2016)

Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma
por: Huang, Wei, et al.
Publicado: (2020)

SMARCB1/INI1 loss in skull base conventional chordomas: a clinicopathological and molecular analysis
por: Righi, Alberto, et al.
Publicado: (2023)

Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma
por: Feng, Wenlong, et al.
Publicado: (2020)

Expression of cyclin D1 and cyclin E in human gastric carcinoma and its clinicopathologic significance.
por: Ahn, M. J., et al.
Publicado: (1998)

ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancer
por: Feng, Wenlong, et al.
Publicado: (2020)

Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma
por: Feng, Yong, et al.
Publicado: (2015)

Histochemical and immunohistochemical characterization of chordoma in ferrets
por: YUI, Takeshi, et al.
Publicado: (2015)

The Immune Microenvironment of Chordomas: An Immunohistochemical Analysis
por: Dridi, Maroa, et al.
Publicado: (2021)

The role of extracelluar matrix in osteosarcoma progression and metastasis
por: Cui, Juncheng, et al.
Publicado: (2020)

Autophagic Markers in Chordomas: Immunohistochemical Analysis and Comparison with the Immune Microenvironment of Chordoma Tissues
por: Karpathiou, Georgia, et al.
Publicado: (2021)

Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels
por: Rubino, Franco, et al.
Publicado: (2022)

A correlation analysis of sacrococcygeal chordoma imaging and clinical characteristics with the prognostic factors
por: Zhao, Fei, et al.
Publicado: (2022)

Exosomes promote pre-metastatic niche formation in ovarian cancer
por: Feng, Wenlong, et al.
Publicado: (2019)

Clinicopathological Significance and Prognostic Implications of REG4 Immunohistochemical Expression in Colorectal Cancer
por: Kang, Guhyun, et al.
Publicado: (2021)

Inhibition of cyclin-dependent kinase 4 as a potential therapeutic strategy for treatment of synovial sarcoma
por: Li, Xiaoyang, et al.
Publicado: (2018)

Prognostic and clinicopathological significance of pretreatment mean platelet volume in cancer: a meta-analysis
por: Chen, Xin, et al.
Publicado: (2020)

The Clinicopathological Significance and Prognostic Value of Androgen Receptor in Endometrial Carcinoma: A Meta-Analysis
por: Wu, Xirong, et al.
Publicado: (2022)

Characteristics and Patterns of Metastatic Disease from Chordoma
por: Young, Victoria A., et al.
Publicado: (2015)

Methylation-based reclassification and risk stratification of skull-base chordomas
por: Huo, Xulei, et al.
Publicado: (2022)

The Clinicopathological and Prognostic Significance of SOX9 Expression in Gastric Cancer: Meta-Analysis and TCGA Analysis
por: Zu, Guo, et al.
Publicado: (2021)

Treatment-Emergent Neuroendocrine Prostate Cancer: A Clinicopathological and Immunohistochemical Analysis of 94 Cases
por: Zhang, Qingfu, et al.
Publicado: (2021)

Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis
por: Sun, Xi, et al.
Publicado: (2017)

Prognostic Significance of Immunohistochemical Markers and Genetic Alterations in Malignant Peripheral Nerve Sheath Tumors: A Systematic Review
por: Martin, Enrico, et al.
Publicado: (2020)

Clinical Implication of Systemic Immune-Inflammation Index and Prognostic Nutritional Index in Skull Base Chordoma Patients
por: Li, Mingxuan, et al.
Publicado: (2021)

Editorial: Chordoma: advances in biology and clinical management
por: Gardner, Paul, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ghc4ekoh3lcipmf3j2m10rumn1